Advertisement
Advertisement
EDSA
Edesa Biotech, Inc. Common Shares
1.13
USDSponsored
0.00
+0.45%
Feb 06, 15:59 UTC -5
Closed
After-Market
1.12
0.00
-0.44%
EDSA Earnings Reports
Positive Surprise Ratio
EDSA beat 19 of 29 last estimates.
66%
Next Report
Next Week
Date of Next Report
Feb 12, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/-$0.45
Implied change from Q4 25 (Revenue/ EPS)
--
/+40.63%
Implied change from Q1 25 (Revenue/ EPS)
--
/-6.25%
Edesa Biotech, Inc. Common Shares earnings per share and revenue
On Dec 12, 2025, EDSA reported earnings of -0.32 USD per share (EPS) for Q4 25, missing the estimate of -0.27 USD, resulting in a -17.65% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -16.09% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.45 USD, with revenue projected to reach -- USD, implying an increase of 40.63% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AYTU BioPharma, Inc. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
-$0.61
Actual
-$1.05
Surprise
-71.57%
Amgen Inc
Report Date
Feb 03, 2026 For Q4 25
Estimate
$4.82
Actual
$5.29
Surprise
+9.56%
Bristol-Myers Squibb Co.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.12
Actual
$1.26
Surprise
+11.88%
GSK plc - ADR
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.23
Actual
$0.49
Surprise
+111.36%
Biogen Inc. Common Stock
Report Date
Feb 06, 2026 For Q4 25
Estimate
$1.62
Actual
$1.99
Surprise
+22.39%
Illumina Inc
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.24
Actual
$1.35
Surprise
+8.01%
QIAGEN N.V.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.64
Actual
$0.62
Surprise
-3.32%
Arrowhead Research Corporation
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.25
Actual
$0.22
Surprise
-14.76%
Bio-Techne Corp.
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.44
Actual
$0.46
Surprise
+3.95%
Immunovant, Inc. Common Stock
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.72
Actual
-$0.61
Surprise
+16.27%
FAQ
What were Edesa Biotech, Inc. Common Shares's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Edesa Biotech, Inc. Common Shares reported EPS of -$0.32, missing estimates by -17.65%, and revenue of $0.00, 0% as expectations.
How did the market react to Edesa Biotech, Inc. Common Shares's Q4 2025 earnings?
The stock price moved down -16.09%, changed from $1.74 before the earnings release to $1.46 the day after.
When is Edesa Biotech, Inc. Common Shares expected to report next?
The next earning report is scheduled for Feb 12, 2026.
What are the forecasts for Edesa Biotech, Inc. Common Shares's next earnings report?
Based on 4
analysts, Edesa Biotech, Inc. Common Shares is expected to report EPS of -$0.45 and revenue of -- for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement